BeiGene
BGNE
#967
Rank
NZ$35.15 B
Marketcap
$321.30
Share price
0.49%
Change (1 day)
12.25%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company